Entheon Biomedical Corp. (1XU)
Market Open
10 Aug, 06:02
XMUN 
€
0. 04
0
0%
€
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
€ 0.04
Previous Close Want to track 1XU and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
1XU trading today higher at €0.04, an increase of 0% from yesterday's close, completing a monthly increase of 0% or €0. Over the past 12 months, 1XU stock lost -44.9612%.
1XU is not paying dividends to its shareholders.
The last earnings report, released on Jul 02, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Entheon Biomedical Corp. has completed 1 stock splits, with the recent split occurring on Mar 01, 2024.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).
1XU Chart
Entheon Biomedical Corp. (1XU) FAQ
What is the stock price today?
The current price is €0.04.
On which exchange is it traded?
Entheon Biomedical Corp. is listed on XMUN.
What is its stock symbol?
The ticker symbol is 1XU.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has Entheon Biomedical Corp. ever had a stock split?
Entheon Biomedical Corp. had 1 splits and the recent split was on Mar 01, 2024.
Entheon Biomedical Corp. Profile
| Biotechnology Industry | Healthcare Sector | Mr. Timothy Ko CEO | XMUN Exchange | CA29383X2023 ISIN |
| Germany Country | - Employees | - Last Dividend | 1 Mar 2024 Last Split | - IPO Date |
Overview
Entheon Biomedical Corp. is a pioneering biotechnology research and development company with its headquarters situated in the vibrant city of Vancouver, Canada. Positioned at the forefront of the biotechnology sector, Entheon is dedicated to the noble mission of combating addiction and substance use disorders. By navigating the complex challenges of drug dependency, Entheon Biomedical Corp. is leading the path towards innovative treatment solutions that promise to transform the landscape of addiction recovery and offer new hope to individuals struggling with such conditions.
Products and Services
- Addiction Treatment Solutions: At the core of Entheon Biomedical's product lineup is a suite of cutting-edge addiction treatment solutions. Leveraging the latest in biotechnological advancements, these treatments are designed with the specific aim of addressing and mitigating the profound challenges posed by various substance use disorders. By focusing on the root causes of addiction, Entheon aims to deliver therapeutic options that offer a more effective and sustainable path to recovery.
- Research and Development in Substance Use Disorders: Entheon Biomedical Corp. is deeply engaged in ongoing research and development efforts targeted at substance use disorders. This includes pioneering studies into innovative drug formulations, treatment protocols, and potential therapeutic interventions. Through rigorous clinical trials and research collaborations, Entheon is at the forefront of developing new knowledge and understanding in the field, driving forward the possibilities for treatment efficacy and patient outcomes.
Contact Information
Address: 999 West Broadway
Phone: 604 562 3932
Website: https://www.entheonbiomedical.com
